Didembourg M
ORCID: 0000-0002-9170-0314
· 1 paper in corpus
review
2026
BACKGROUND: Relugolix, an oral GnRH receptor antagonist, is effective in treating uterine myomas and endometriosis. However, concerns persist regarding the venous thromboembolism (VTE) risk associated with its combination with oral estradio…